Information Provided By:
Fly News Breaks for March 29, 2016
KERX
Mar 29, 2016 | 13:44 EDT
Maxim raised Buy rated Keryx's price target to $7 following positive Phase III study data of Ferric Citrate for the treatment of iron deficiency anemia in adults with non-dialysis dependent chronic kidney disease.
News For KERX From the Last 2 Days
There are no results for your query KERX